These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 47195)

  • 41. A new assay for the measurement of total progressive antithrombin.
    Lane JL; Bird P; Rizza CR
    Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions between heparin and factor Xa. Inhibition of prothrombin activation.
    Walker FJ; Esmon CT
    Biochim Biophys Acta; 1979 Jul; 585(3):405-15. PubMed ID: 486539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The conversion of prothrombin to thrombin. III. The factor Xa-catalyzed activation of prothrombin.
    Esmon CT; Jackson CM
    J Biol Chem; 1974 Dec; 249(24):7782-90. PubMed ID: 4430674
    [No Abstract]   [Full Text] [Related]  

  • 44. Studies on the binding of heparin to prothrombin and thrombin and the effect of heparin-binding on thrombin activity.
    Nordenman B; Björk I
    Thromb Res; 1978 May; 12(5):755-65. PubMed ID: 675585
    [No Abstract]   [Full Text] [Related]  

  • 45. Normal human plasma contains a naturally occurring antagonist of activated factor X inhibitor (antithrombin III) activity.
    Yin ET; Salsgiver WJ; Tangen O
    Thromb Res; 1979; 15(3-4):557-61. PubMed ID: 494161
    [No Abstract]   [Full Text] [Related]  

  • 46. Biological properties of the naturally occurring plasma inhibitor to activated factor X.
    Yin ET; Wessler S; Stoll PJ
    J Biol Chem; 1971 Jun; 246(11):3703-11. PubMed ID: 5578915
    [No Abstract]   [Full Text] [Related]  

  • 47. Platelet-derived heparin neutralizing proteins.
    Lane DA
    Adv Exp Med Biol; 1985; 192():427-38. PubMed ID: 2939696
    [No Abstract]   [Full Text] [Related]  

  • 48. Bovine antithrombin-III: miscellaneous observations.
    Seegers WH; Novoa E; Andary TJ; Hassouna HI
    Thromb Res; 1977 Dec; 11(6):809-15. PubMed ID: 601751
    [No Abstract]   [Full Text] [Related]  

  • 49. Identification of a heparin activated amidolytic enzyme in carp (Cyprinus carpio) plasma.
    Atkinson PM; Walker NP; Niehaus A; Bradlow BA; Smith G
    Thromb Res; 1983 Feb; 29(3):289-97. PubMed ID: 6342205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithrombin 3. Protection against death after injection of thromboplastin.
    Mann LT; Jensenius JC; Simonsen M; Abildgaard U
    Science; 1969 Oct; 166(3904):517-8. PubMed ID: 4186074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two progressive inhibitors of factor Xa in human blood.
    Marciniak E; Tsukamura S
    Br J Haematol; 1972 Mar; 22(3):341-51. PubMed ID: 5062540
    [No Abstract]   [Full Text] [Related]  

  • 52. Thrombin inhibitory activity of fractions obtained by gel filtration of antithrombin 3 deficient plasma.
    Abildgaard U; Egeberg O
    Scand J Haematol; 1968; 5(2):155-7. PubMed ID: 5673827
    [No Abstract]   [Full Text] [Related]  

  • 53. Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease.
    Lewis JH; Iammarino RM; Spero JA; Hasiba U
    Blood; 1978 Jan; 51(1):129-37. PubMed ID: 412531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence of a catalytic role of heparin in anticoagulation reactions.
    Gitel SN
    Adv Exp Med Biol; 1975; 52():243-7. PubMed ID: 1124699
    [No Abstract]   [Full Text] [Related]  

  • 55. Heparin prevents thrombin inhibition by alpha 2 macroglobulin.
    Fischer AM; Bros A; Rafowicz S; Josso F
    Thromb Res; 1980 May 1-15; 18(3-4):567-71. PubMed ID: 6158112
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma.
    Abildgaard U; Fagerhol MK; Egeberg O
    Scand J Clin Lab Invest; 1970 Dec; 26(4):349-54. PubMed ID: 4098730
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of a natural heparinoid with sodium and calcium heparin for their effect on the inhibitor of activated factor X.
    Mannucci PM; di Santo C; Franchi F
    Experientia; 1976 Nov; 32(11):1478-80. PubMed ID: 62674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of size-exclusion high-performance liquid chromatography for the analysis of the activation of prothrombin.
    Kosow DP; Morris S; Orthner CL; Rhee MJ
    Anal Biochem; 1982 Nov; 126(2):425-32. PubMed ID: 6897607
    [No Abstract]   [Full Text] [Related]  

  • 59. [Relation between variations of plasmatic clearing and antithrombin power after heparin and fatty meal].
    DULBECCO A; GAIDA A; PIASCO D
    Minerva Med; 1962 Jun; 53():1930-2. PubMed ID: 13888345
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence that antithrombin and the inhibitor of activated Stuart-Prower factor are separate entities.
    Osamo NO
    Blut; 1971 Nov; 23(5):280-6. PubMed ID: 5131050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.